Brief: Onxeo Receives U.S. Patent And Trademark Office Notice Of Allowance For New Patent Protecting Asidna™
Nov 4 (Reuters) - ONXEO SA C4X.PA :
* ONXEO RECEIVES U.S. PATENT AND TRADEMARK OFFICE NOTICE OF
ALLOWANCE FOR NEW PATENT PROTECTING COMBINATION OF ASIDNA™ WITH
ANY PARP INHIBITOR FOR CANCER TREATMENT
* NEW U.S. PATENT, IS VALID UNTIL 2036
* IT FURTHER EXPANDS ONXEO'S INTELLECTUAL PROPERTY PORTFOLIO
FOR
ASIDNA™, WHICH NOW INCLUDES 168 NUMBER OF PATENTS GLOBALLY.
Source text for Eikon: ID:nBw4Fdzjba
Further company coverage: C4X.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln